Trial Profile
Phase II Study: Neoadjuvant Gemcitabine, Docetaxel and Capecitabine Followed by Neoadjuvant Radiation Therapy With Gemcitabine in the Treatment of Stage II and III Pancreatic Adenocarcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Gemcitabine (Primary) ; Dexamethasone; Filgrastim; Pegfilgrastim
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 19 Feb 2010 New trial record